NASDAQ
Cognition Therapeutics, Inc. (CGTX) has a fcf yield of -25.03% as of Friday, May 29, 2026. This represents a 39.20% increase compared to its 12-month average of -41.17%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.